Spevigo

spesolimab-sbzo

Approval

ApplicationBLA 761244
Approval dateSep 1, 2022
Approval year2022
SponsorBoehringer Ingelheim Pharmaceuticals INC

FDA-approved use

To treat generalized pustular psoriasis flares

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Spevigo: